A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies (Q45459054)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 March 2005

Language	Label	Description	Also known as
English	A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies	scientific article published on 16 March 2005

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies (English)

1 reference

Europe PubMed Central

14 December 2017

viral nucleocapsid

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

Rainer G. Ulrich

7

object named as

Rainer Ulrich

1 reference

Europe PubMed Central

14 December 2017

author name string

Astrid Geldmacher

1

1 reference

Europe PubMed Central

14 December 2017

Dace Skrastina

2

1 reference

Europe PubMed Central

14 December 2017

Galina Borisova

3

1 reference

Europe PubMed Central

14 December 2017

Ivars Petrovskis

4

1 reference

Europe PubMed Central

14 December 2017

Detlev H Krüger

5

1 reference

Europe PubMed Central

14 December 2017

Paul Pumpens

6

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

16 March 2005

1 reference

Europe PubMed Central

14 December 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

14 December 2017

23

1 reference

Europe PubMed Central

14 December 2017

30

1 reference

Europe PubMed Central

14 December 2017

3973-3983

1 reference

Europe PubMed Central

14 December 2017

Hepatitis B virus genes and their expression in E. coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Physicochemical analysis of the hepatitis B virus core antigen produced by a baculovirus expression vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Unusually high-level expression of a foreign gene (hepatitis B virus core antigen) in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Expression of hepatitis B virus core and precore antigens in insect cells and characterization of a core-associated kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Electron microscopy of hepatitis B core antigen synthesized in E. coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

The crystal structure of the human hepatitis B virus capsid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Interaction of wild-type and naturally occurring deleted variants of hepatitis B virus core polypeptides leads to formation of mosaic particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Immunological properties of hepatitis B core antigen fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Retrospective serological and genetic study of the distribution of hantaviruses in Greece.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Hemorrhagic fever with renal syndrome in the Dolenjska region of Slovenia--a 10-year survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Genetic interaction between distinct Dobrava hantavirus subtypes in Apodemus agrarius and A. flavicollis in nature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Isolation and characterization of Dobrava hantavirus carried by the striped field mouse (Apodemus agrarius) in Estonia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

First molecular identification of human Dobrava virus infection in central Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Hantavirus infections in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Emerging viruses: the case 'hantavirus'.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Hantaviruses in Estonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Isolation of the Etiologic Agent of Korean Hemorrhagic Fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Hantavirus infections and their prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Review of an inactivated vaccine against hantaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Primary humoral immune responses to formalin inactivated hemorrhagic fever with renal syndrome vaccine (Hantavax): consideration of active immunization in South Korea

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Immunity to Hantavirus challenge in Meriones unguiculatus induced by vaccinia-vectored viral proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Genetic vaccines protect against Sin Nombre hantavirus challenge in the deer mouse (Peromyscus maniculatus)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Characterization of Puumala virus nucleocapsid protein: identification of B-cell epitopes and domains involved in protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Genetic and antigenic properties of Dobrava virus: a unique member of the Hantavirus genus, family Bunyaviridae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Coding strategy of the S and M genomic segments of a hantavirus representing a new subtype of the Puumala serotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

High yields of stable and highly pure nucleocapsid proteins of different hantaviruses can be generated in the yeast Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Yeast-expressed hantavirus Dobrava nucleocapsid protein induces a strong, long-lasting, and highly cross-reactive immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

The immunoglobulin class switch: beyond "accessibility".

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

based on heuristic

inferred from DOI database lookup

A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell culture adaptation of Puumala hantavirus changes the infectivity for its natural reservoir, Clethrionomys glareolus, and leads to accumulation of mutants with altered genomic RNA S segment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.02.025

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45459054&oldid=2076965960"